These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

485 related articles for article (PubMed ID: 20812533)

  • 1. Is it possible to predict post-residual voided urine by bladder scan before uroflowmetry--a useful and timesaving test to reduce the number of non--evaluable uroflow measurements?
    Dicuio M; Vesely S; Knutson T; Damber JE; Cuzzocrea DE; Dahlstrand C
    Arch Ital Urol Androl; 2010 Jun; 82(2):100-4. PubMed ID: 20812533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Usefulness of a prevoiding transabdominal sonographic bladder scan for uroflowmetry in patients involved in clinical studies of benign prostatic hyperplasia.
    Dicuio M; Creti S; Di Campli A; Dipietro R; Mannini D; Nanni G; Dahlstrand C; Cuzzocrea DE
    J Ultrasound Med; 2003 Aug; 22(8):773-6. PubMed ID: 12901403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical evaluation of patients with prostatic obstruction: correlation of flow rates with voided, residual or total bladder volume.
    Drach GW; Steinbronn DV
    J Urol; 1986 Apr; 135(4):737-40. PubMed ID: 2421016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Data from frequency-volume charts versus maximum free flow rate, residual volume, and voiding cystometric estimated urethral obstruction grade and detrusor contractility grade in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia.
    Van Venrooij GE; Eckhardt MD; Boon TA
    Neurourol Urodyn; 2002; 21(5):450-6. PubMed ID: 12232879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of voiding position on uroflowmetric parameters and post-void residual urine volume in patients with benign prostatic hyperplasia.
    Unsal A; Cimentepe E
    Scand J Urol Nephrol; 2004; 38(3):240-2. PubMed ID: 15204379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic accuracy of noninvasive tests to evaluate bladder outlet obstruction in men: detrusor wall thickness, uroflowmetry, postvoid residual urine, and prostate volume.
    Oelke M; Höfner K; Jonas U; de la Rosette JJ; Ubbink DT; Wijkstra H
    Eur Urol; 2007 Sep; 52(3):827-34. PubMed ID: 17207910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accuracy of post-void residual urine volume measurement using a portable ultrasound bladder scanner with real-time pre-scan imaging.
    Park YH; Ku JH; Oh SJ
    Neurourol Urodyn; 2011 Mar; 30(3):335-8. PubMed ID: 20658544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ultrasound estimated bladder weight in men attending the uroflowmetry clinic.
    Bright E; Pearcy R; Abrams P
    Neurourol Urodyn; 2011 Apr; 30(4):583-6. PubMed ID: 21308749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of Voiding Position on Uroflowmetry Parameters and Post Void Residual Urine in Patients With Benign Prostatic Hyperplasia and Healthy Men.
    Alrabadi A; Al Demour S; Mansi H; AlHamss S; Al Omari L
    Am J Mens Health; 2020; 14(4):1557988320938969. PubMed ID: 32660326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of silodosin for relieving benign prostatic obstruction: prospective pressure flow study.
    Matsukawa Y; Gotoh M; Komatsu T; Funahashi Y; Sassa N; Hattori R
    J Urol; 2009 Dec; 182(6):2831-5. PubMed ID: 19837428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does sildenafil affect uroflowmetry values in men with lower urinary tract symptoms suggestive of benign prostatic enlargement?
    Güler C; Tüzel E; Doğantekin E; Kiziltepe G
    Urol Int; 2008; 80(2):181-5. PubMed ID: 18362490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship of flow rate with symptoms, quality of life and other clinical parameters in patients with LUTS suggestive of BPH.
    Porru D; Bartoletti R; Austoni E; Carrino M; Gianneo E; Melloni D
    Eur Urol; 2001; 40 Suppl 1():23-7. PubMed ID: 11598350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Challenging the maximum flow rate: a new index of voiding dysfunction in men with benign prostatic enlargement.
    Valentini FA; Nelson PP; Besson GR; Zimmern PE
    BJU Int; 2008 Apr; 101(8):995-9. PubMed ID: 18241248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Diagnostic values and limitations of conventional urodynamic studies (uroflowmetry.residual urine measurement.cystometry) in benign prostatic hypertrophy].
    Gotoh M; Yoshikawa Y; Kondo A; Kato N; Ono Y; Kondo T; Nagai T; Sakakibara T; Kondo A; Miyake K
    Nihon Hinyokika Gakkai Zasshi; 1996 Dec; 87(12):1321-30. PubMed ID: 8997080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of bladder outlet obstruction and detrusor contractility on residual urine in patients with benign prostatic hyperplasia.
    Zhang P; Wu Z; Gao J
    Chin Med J (Engl); 2003 Oct; 116(10):1508-10. PubMed ID: 14570611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of bladder over distention on voiding function in kindergarteners.
    Yang SS; Chang SJ
    J Urol; 2008 Nov; 180(5):2177-82; discussion 2182. PubMed ID: 18804816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Residual fraction in the evaluation of bladder outlet obstruction resulting from benign prostatic hyperplasia].
    Cheng W; Gao JP; Zhang ZY; Ge JP; Xue S
    Zhonghua Nan Ke Xue; 2003; 9(4):273-4. PubMed ID: 12931369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can ultrasonography or uroflowmetry predict which children with voiding dysfunction will have recurrent urinary tract infections?
    Shaikh N; Abedin S; Docimo SG
    J Urol; 2005 Oct; 174(4 Pt 2):1620-2; discussion 1622. PubMed ID: 16148667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the clinical value of a simple flowmeter in the management of male lower urinary tract symptoms.
    Chan CK; Yip SK; Wu IP; Li ML; Chan NH
    BJU Int; 2012 Jun; 109(11):1690-6. PubMed ID: 21933332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in peak urinary flow and voiding efficiency in men with signs and symptoms of benign prostatic hyperplasia during once daily tadalafil treatment.
    Roehrborn CG; Kaminetsky JC; Auerbach SM; Montelongo RM; Elion-Mboussa A; Viktrup L
    BJU Int; 2010 Feb; 105(4):502-7. PubMed ID: 19732051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.